Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Oculis Announces Completion of Last Patient Visit in Phase 3 DIAMOND Program with OCS-01 Eye Drops for the Treatment of Diabetic Macular Edema
GlobeNewswire, Inc.
Last patient visits for both OCS-01 Phase 3 DIAMOND trials (total 800+ patients) are complete, with topline results expected in June 2026 A non-invasive topical treatment for diabetic macular edema (DME) has the potential to address significant...
Jacada Travel’s Summer Trends Reveal the Rise of Legacy and Learning in Luxury Tourism
EIN Presswire
How alternative wildlife tracking, blockbuster-inspired itineraries, and private lodges for multi-generational groups are reshaping the luxury landscape LONDON, ENGLAND, UNITED KINGDOM, June 30, 2026 /EINPresswire.com/ -- Jacada Travel‘s summer...
Ojemda® approved in the European Union as the first targeted therapy in relapsed or refractory pediatric low-grade glioma regardless of BRAF alteration
GlobeNewswire, Inc.
New treatment option for rare, life-altering pediatric brain tumors Less than 10% of new medicine approvals over the past five years have focused on pediatric diseases; Ojemda® (tovorafenib) represents a rare achievement that reinforces the urgent...
Alvotech enters supply and commercialization agreements for Canada and Australia & New Zealand covering multiple biosimilar candidates
GlobeNewswire, Inc.
REYKJAVIK, Iceland, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that it has entered into...
VIVUS Announces QSIVA® Price Reduction Across Nordics and Poland
GlobeNewswire, Inc.
— The new pricing structure is made available as of February for 566,13 ISK per day at pharmacies throughout Iceland AMSTERDAM, March 10, 2026 (GLOBE NEWSWIRE) -- VIVUS BV, a subsidiary of VIVUS LLC, a biopharmaceutical company committed to the...
Alvotech Secures Settlement Agreement in Global Markets for its Biosimilar to Eylea® 2mg
GlobeNewswire, Inc.
REYKJAVIK, Iceland, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that it has reached a...
Oculis to Participate in Upcoming Investor Conferences
GlobeNewswire, Inc.
ZUG, Switzerland, April 07, 2026 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with...
Liminal Diplomacy at the Poles: Japan’s Disaster Risk Reduction and the Making of Arctic Order
The Arctic Institute
Back to Publications Japan’s former Arctic Ambassador, Keizo Takewaka, delivering a speech at the 2022 Arctic Circle Assembly held October 13–16 in Reykjavík, Iceland.
Eythor Arnalds Unveils Meditative New Single ‘Body Of Water,’ a Neo-Classical Soundtrack for Walking and Reflection
EIN Presswire
REYKJAVIK, ICELAND, January 29, 2026 /EINPresswire.com/ -- Icelandic cellist and composer Eythor Arnalds releases “Body Of Water,” a quietly immersive new single that drifts through the space between contemporary classical, minimalist...
The Arctic Ocean and the WTO Fisheries Subsidies Agreement
The Arctic Institute
Back to Publications Ships in the port of Longyearbyen, Svalbard.
2026 Production and Financial Guidance and Exploration Update
GlobeNewswire, Inc.
Reykjavík, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Amaroq Ltd. (“Amaroq” or the “Company”) 2026 Production and Financial Guidance and Exploration Update TORONTO, ONTARIO – 25 February 2026 – Amaroq Ltd. (AIM, TSX-V, NASDAQ Iceland: AMRQ, OTCQX: AMRQF),...
Fervo Energy: Pioneering Next-Generation Geothermal Power
Berkeley Lab - California
[00:00:00] Soomin Suh: Hi everyone.
Oculis Announces European Medicines Agency PRIME Designation for Privosegtor, Advancing a Potential First‑in‑Class Neuroprotective Candidate for Optic Neuritis
GlobeNewswire, Inc.
PRIME designation follows recent Breakthrough Therapy designation from the U.S. FDA, underscoring the importance and urgency of addressing optic neuritis, a serious condition that can have negative long-term visual outcomes, significantly...
Oculis Appoints Katie Kazem as Chief Legal Officer
GlobeNewswire, Inc.
Ms. Kazem brings extensive and global expertise in corporate governance and securities law, drawing on a distinguished track record as external legal counsel to leading life sciences companies Chief Legal Officer (CLO) appointment enhances...
There is a Missing Link Between Identity Verification and Qualified Signatures in European Onboarding
EIN Presswire
Shufti and Evrotrust partner to combine identity verification and Qualified Electronic Signatures in a single onboarding journey across all 27 EU member states.
DDG Nordquist highlights role of trade remedies amid global trade challenges at Seoul Forum
World Trade Organization
I'm honored to be here to address the 24th Annual Seoul International Forum on Trade Remedies.
BlueCat appoints Jeff McCullough as Vice President, Worldwide Channel and Alliance
GlobeNewswire, Inc.
NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- BlueCat Networks, the leader in Intelligent NetOps, today announced the appointment of Jeff McCullough as Vice President, Worldwide Channel and Alliance.
From design to daily operations: Flashnet's customer-centric support services for more reliable smart street lighting
EIN Presswire
While the technology is complex underneath, Flashnet’s goal is to make it manageable & clear for people using it everyday through advising, training & support.
Pharming Group receives positive CHMP opinion for Joenja® (leniolisib) for the treatment of APDS in adult and pediatric patients 12 years and older
GlobeNewswire, Inc.
If approved, Joenja® (leniolisib) would become the first approved treatment in the European Union for activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS), a rare primary immunodeficiency Decision based on Phase II/III clinical data...
Brussels Just Opened Its Critical-Raw-Materials Door to a Greenland Palladium-Gold-Platinum Project — and the Company Behind It Trades on the Nasdaq
GlobeNewswire, Inc.
Greenland Mines Ltd. (NASDAQ: GRML) and its 80%-owned Greenland subsidiary Major Precious Greenland A/S have been admitted to the European Raw Materials Alliance — the European Commission’s central industrial mechanism for translating...
Sign up for:
Sci-Tech Press Iceland
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.